Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Westerman

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Pathology|June 7, 2000
Test and teach. Number one hundred and one: Part 1D A Westerman, S K Juneja
The Medical Journal of Australia|March 27, 1999
The diagnosis of idiopathic thrombocytopenic purpura in adults: does bone marrow biopsy have a place?D A Westerman, A P Grigg
British Journal of Haematology|December 3, 1999
Neutrophil hypersegmentation in iron deficiency anaemia: a case-control studyD A Westerman, D Evans, J Metz
Australian and New Zealand Journal of Medicine|December 16, 1998
Hydroxyurea-induced fever and hepatitisD A Westerman, A Schwarer, A P Grigg
Pathology|January 22, 2000
Fatal disseminated infection by Scedosporium prolificans during induction therapy for acute leukemia: a case report and literature reviewD A Westerman, B R Speed, H M Prince
The Journal of Trauma|May 1, 1986
Factors influencing DRG 210 (hip fracture) reimbursementN Agarwal, J D Reyes, D A Westerman, et al.
Leukemia Research|September 1, 2018
"Reversible" myelodysplastic syndrome or ineffectual clonal haematopoiesis? - add(6p) myeloid neoplasm with a spontaneous cytogenetic remissionK Rady, P Blombery, D A Westerman, et al.
Clinical and Experimental Neurology|January 1, 1988
Effects of topical capsaicin on normal skin and affected dermatomes in herpes zosterR A Westerman, R G Roberts, R R Kotzmann, et al.
Bone Marrow Transplantation|June 3, 2014
Plerixafor plus pegfilgrastim is a safe, effective mobilization regimen for poor or adequate mobilizers of hematopoietic stem and progenitor cells: a phase I clinical trialK E Herbert, L Demosthenous, G Wiesner, et al.
Leukemia|November 7, 2008
Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparatorK E Herbert, S Morgan, H M Prince, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Pathology|June 7, 2000
Test and teach. Number one hundred and one: Part 1D A Westerman, S K Juneja
The Medical Journal of Australia|March 27, 1999
The diagnosis of idiopathic thrombocytopenic purpura in adults: does bone marrow biopsy have a place?D A Westerman, A P Grigg
British Journal of Haematology|December 3, 1999
Neutrophil hypersegmentation in iron deficiency anaemia: a case-control studyD A Westerman, D Evans, J Metz
Australian and New Zealand Journal of Medicine|December 16, 1998
Hydroxyurea-induced fever and hepatitisD A Westerman, A Schwarer, A P Grigg
Pathology|January 22, 2000
Fatal disseminated infection by Scedosporium prolificans during induction therapy for acute leukemia: a case report and literature reviewD A Westerman, B R Speed, H M Prince
The Journal of Trauma|May 1, 1986
Factors influencing DRG 210 (hip fracture) reimbursementN Agarwal, J D Reyes, D A Westerman, et al.
Leukemia Research|September 1, 2018
"Reversible" myelodysplastic syndrome or ineffectual clonal haematopoiesis? - add(6p) myeloid neoplasm with a spontaneous cytogenetic remissionK Rady, P Blombery, D A Westerman, et al.
Clinical and Experimental Neurology|January 1, 1988
Effects of topical capsaicin on normal skin and affected dermatomes in herpes zosterR A Westerman, R G Roberts, R R Kotzmann, et al.
Bone Marrow Transplantation|June 3, 2014
Plerixafor plus pegfilgrastim is a safe, effective mobilization regimen for poor or adequate mobilizers of hematopoietic stem and progenitor cells: a phase I clinical trialK E Herbert, L Demosthenous, G Wiesner, et al.
Leukemia|November 7, 2008
Stem cell factor and high-dose twice daily filgrastim is an effective strategy for peripheral blood stem cell mobilization in patients with indolent lymphoproliferative disorders previously treated with fludarabine: results of a Phase II study with an historical comparatorK E Herbert, S Morgan, H M Prince, et al.
Pageof 2